| Filed On | Filing |
|---|---|
| 17 Jul 2017 |
Form 3/A: Paulson John, Director
Holds 21,813,400 shares of Common Stock, no par value |
| 08 Mar 2012 | Form 3/A: Hall Susan, Global Head of R&D |
| 13 Apr 2011 |
Form 3/A: Masterson Richard Kevin, President,Biovail Labs Int SRL
Holds 5,789 shares of Common Stock, no par value |
| 11 Apr 2011 |
Form 3/A: Loberg Philip Walden Jr, EVP, Interim CFO
Holds 20,000 shares of Common Stock, no par value |
| 08 Jan 2010 |
Form 3/A: Potter Frank, Director
Holds 1,500 shares of Common Stock, no par value |
| 05 Jan 2010 | Form 3/A: Parrish Mark W, Director |
Loading...
